参考文献/References:
[1] Ghouri YA,Tahan V,Shen B.Secondary causes of inflammatory bowel diseases[J].World J Gastroenterol,2020,26(28):3998-4017.
[2] Casey G.Inflammatory bowel disease[J].Nurs N Z,2017,23(2):20-24.
[3] Park SH,Park SH.Personalized medicine in inflammatory bowel disease:Perspectives on Asia[J].J Gastroenterol Hepatol,2022,37(8):1434-1445.
[4] 尹硕鑫,张 涛,王舒萍,等.维得利珠单抗诱导和维持炎症性肠病疗效Meta分析[J].陕西医学杂志,2022,51(1):103-110.
[5] Schwarz DS,Blower MD.The endoplasmic reticulum:Structure,function and response to cellular signaling[J].Cell Mol Life Sci,2016,73(1):79-94.
[6] Perkins HT,Allan V.Intertwined and finely balanced:Endoplasmic reticulum morphology,dynamics,function,and diseases[J].Cells,2021,10(9):2341.
[7] Almanza A,Carlesso A,Chintha C,et al.Endoplasmic reticulum stress signaling-from basic mechanisms to clinical applications[J].Febs J,2019,286(2):241-278.
[8] Qi Z,Chen L.Endoplasmic reticulum stress and autophagy[J].Adv Exp Med Biol,2019,120(6):167-177.
[9] Cao SS,Luo KL,Shi L.Endoplasmic reticulum stress interacts with inflammation in human diseases[J].J Cell Physiol,2016,231(2):288-294.
[10] Lee SH,Kwon JE,Cho ML.Immunological pathogenesis of inflammatory bowel disease[J].Intest Res,2018,16(1):26-42.
[11] Resende R,Fernandes T,Pereira AC,et al.Mitochondria,endoplasmic reticulum and innate immune dysfunction in mood disorders:Do mitochondria-associated membranes(MAMs)play a role?[J].Biochim Biophys Acta Mol Basis Dis,2020,1866(6):165752.
[12] 胡 甜,申月明,曾 亚.内质网应激在炎症性肠病免疫调节中的作用[J].国际消化病杂志,2021,41(1):15-18,44.
[13] Martinvalet D.The role of the mitochondria and the endoplasmic reticulum contact sites in the development of the immune responses[J].Cell Death Dis,2018,9(3):336.
[14] Xu X,Lai Y,Hua ZC.Apoptosis and apoptotic body:Disease message and therapeutic target potentials[J].Biosci Rep,2019,39(1):20180992.
[15] 江 东,徐长亮,沈卫星,等.参白解毒方对溃疡性结肠炎肠黏膜上皮细胞保护作用机制研究[J].陕西中医,2022,43(1):23-27.
[16] Iwanaga T,Takahashi-Iwanaga H.Disposal of intestinal apoptotic epithelial cells and their fate via divergent routes[J].Biomed Res,2022,43(3):59-72.
[17] Asadi M,Taghizadeh S,Kaviani E,et al.Caspase-3:Structure,function,and biotechnological aspects[J].Biotechnol Appl Biochem,2022,69(4):1633-1645.
[18] Ren MT,Gu ML,Zhou XX,et al.Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis[J].World J Gastroenterol,2019,25(38):5800-5813.
[19] Li X,Zhu S,Li Z,et al.Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells[J].Free Radic Res,2022,56(5):398-410.
[20] 吴志强,肖玉娇,谷丽瑶,等.基于PERK信号通路介导的细胞凋亡及杯状细胞破坏探讨芍药汤对溃疡性结肠炎大鼠的作用机制[J].陕西中医,2022,43(11):1511-1515.
[21] Marchi S,Patergnani S,Missiroli S,et al.Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death[J].Cell Calcium,2018,69(2):62-72.
[22] Hou Q,Huang J,Ayansola H,et al.Intestinal stem cells and immune cell relationships:Potential therapeutic targets for inflammatory bowel diseases[J].Front Immunol,2021,11(5):623-637.
[23] Jiang Y,Zhang C,Wang T.bFGF ameliorates intestinal mucosal permeability and barrier function through tight junction proteins in burn injury rats[J].Burns,2021,47(5):1129-1136.
[24] Slifer ZM,Blikslager AT.The integral role of tight junction proteins in the repair of injured intestinal epithelium[J].Int J Mol Sci,2020,21(3):972.
[25] 李竹林,赵 瑛.高强度间歇性运动联合药物治疗溃疡性结肠炎疗效及对患者细胞因子水平影响研究[J].陕西医学杂志,2019,48(7):909-912.
[26] 张雅丽,孙佳宁,战晶玉,等.连草泻痢胶囊对溃疡性结肠炎大鼠内质网应激及炎症反应的影响[J].中国中医药信息杂志,2023,30(5):97-103.
[27] 莫达瑜,刘英超,江向红,等.甘草酸苷调节内质网应激PERK-elF2α-NF-κB信号通路治疗溃疡性结肠炎的机制研究[J].时珍国医国药,2022,33(8):1860-1864.
[28] 李 晗,李昆珊,吴璐一,等.针灸对溃疡性结肠炎大鼠维生素D受体及p53信号通路调节作用的研究[J].世界中医药,2020,15(15):2259-2263,2270.
[29] 陈明森.电针“天枢”“足三里”介导FOXP3/DAF通路调控UC大鼠Treg/Th17平衡的机制研究[D].沈阳:辽宁中医药大学,2020.
[30] 吴阳阳,刘明江,殷韶杰,等.针刺对溃疡性结肠炎大鼠氧化应激和内质网应激的影响[J].针刺研究,2020,45(1):8-14.
[31] 李凌倩,曾 亚,申月明,等.内质网应激调控NADPH氧化酶表达在克罗恩病中的作用[J].中南药学,2019,17(5):662-666.
[32] 龙 艳.内质网应激通过P38MAPK通路上调Gro-α、IL-8促进克罗恩病肠道炎症[D].衡阳:南华大学,2019.
[33] 李小珍.内质网应激蛋白和黏蛋白2在小鼠结肠炎中的表达及意义[D].洛阳:河南科技大学,2015.
[34] 曹 攀.具核梭杆菌激活ERS通路在克罗恩病发展中的机制研究[D].武汉:武汉大学,2020.
[35] 赵 华,蒋 洁.针灸调节内质网应激的研究进展[J].针刺研究,2019,44(1):75-79.
[36] 赵桓艺.基于PI3K/AKT探讨针刺调控内质网应激-自噬对哮喘炎症及T细胞亚群的影响[D].广州:广州中医药大学,2021.
[37] 芮靖琳,商志浩,黎柳娇,等.针刺对PERK-CHOP通路及胰腺组织中内质网应激的影响[J].中国老年学杂志,2022,42(12):3034-3036.
相似文献/References:
[1]首汉蓉,唐 建,黄泽林,等.黄芩汤加减联合补脾益肠丸对溃疡性结肠炎患者Toll样受体4/髓样分化因子88信号通路的影响*[J].陕西中医,2020,(6):750.[doi:DOI:10.3969/j.issn.10007369.2020.06.014]
SHOU Hanrong,TANG Jian,HUANG Zelin,et al.Effect of modified Huangqin decoction combined with Bupi Yichang Wan on signaling pathway of Toll like receptor 4/ myeloid differentiation factor 88 in patients with ulcerative colitis[J].,2020,(8):750.[doi:DOI:10.3969/j.issn.10007369.2020.06.014]
[2]杨 阔,韩 毅,刘华一△,等.升阳益胃汤对溃疡性结肠炎模型大鼠HIF-1、TAK-1表达的影响*[J].陕西中医,2020,(7):853.[doi:DOI:10.3969/j.issn.10007369.2020.07.004]
[3]仝建松.基于Janus激酶2/信号转导和转录激活因子3信号通路探讨参苓白术散对溃疡性结肠炎模型大鼠炎症抑制作用研究[J].陕西中医,2021,(8):1010.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
TONG Jiansong.Study on the inhibitory effect of Shenling Baizhu powder on inflammation of ulcerative colitis model rats based on Janus kinase 2/signal transduction and transcription activator 3 signaling pathway[J].,2021,(8):1010.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
[4]杨丽艳,赵宝宁,杨贺庆,等.半夏泻心汤联合美沙拉嗪治疗轻度活动期克罗恩病疗效研究[J].陕西中医,2021,(9):1240.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.023]
YANG Liyan,ZHAO Baoning,YANG Heqing,et al.Efficacy study on Banxia Xiexin decoction combined with mesalazine in treatment of mild active Crohn's disease[J].,2021,(8):1240.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.023]
[5]陶 冉,黄晓琳,龚恬韵,等.克罗恩病肛瘘中医药治疗研究进展[J].陕西中医,2022,(5):666.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.029]
TAO Ran,HUANG Xiaolin,GONG Tianyun,et al.Research progress of traditional Chinese medicine in the treatment of anal fistula in Crohn's disease[J].,2022,(8):666.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.029]
[6]贡钰霞,王 浩.名中医谷云飞内外治结合治疗克罗恩病肛瘘经验[J].陕西中医,2023,(9):1277.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.028]
GONG Yuxia,WANG Hao.The experience of Gu Yunfei in treating anal fistula of Crohn's disease with internal and external treatment[J].,2023,(8):1277.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.028]